AZD 1152 negatively affects the growth of anaplastic thyroid carcinoma cells and enhances the effects of oncolytic virus dl 922-947

@inproceedings{Libertini2011AZD1N,
  title={AZD 1152 negatively affects the growth of anaplastic thyroid carcinoma cells and enhances the effects of oncolytic virus dl 922-947},
  author={Silvana Libertini and Antonella Abagnale and Claudia Passaro and Ginevra Botta and Sara Barbato and Paolo Chieffi and Giuseppe Portella},
  year={2011}
}
Novel therapeutic approaches are required for the treatment of anaplastic thyroid carcinoma (ATC), an incurable disease resistant to current available therapies. Aurora B is an important mitotic kinase involved in chromosome segregation and cytokinesis. It is overexpressed in many cancers including ATC and represents a potential target for chemotherapy. The effects of AZD1152, a specific Aurora B kinase inhibitor, have been evaluated against ATC, showing G2/M accumulation, polyploidy and… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 45 REFERENCES

Bevacizumab increases viral distribution in human anaplastic thyroid carcinoma xenografts and enhances the effects of E1A-defective adenovirus dl922-947.

  • Clinical cancer research : an official journal of the American Association for Cancer Research
  • 2008
VIEW 6 EXCERPTS
HIGHLY INFLUENTIAL

AZD1152, a selective inhibitor of Aurora B kinase, inhibits human tumor xenograft growth by inducing apoptosis.

  • Clinical cancer research : an official journal of the American Association for Cancer Research
  • 2007
VIEW 6 EXCERPTS
HIGHLY INFLUENTIAL

Variation in adenovirus receptor expression and adenovirus vector-mediated transgene expression at defined stages of the cell cycle.

  • Molecular therapy : the journal of the American Society of Gene Therapy
  • 2001
VIEW 6 EXCERPTS
HIGHLY INFLUENTIAL

Mitotic drivers—inhibitors of the Aurora B Kinase

  • Cancer and Metastasis Reviews
  • 2009
VIEW 3 EXCERPTS
HIGHLY INFLUENTIAL

Aurora-kinase inhibitors as anticancer agents

  • Nature Reviews Cancer
  • 2004
VIEW 3 EXCERPTS
HIGHLY INFLUENTIAL

Similar Papers

Loading similar papers…